Literature DB >> 22776878

Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis.

Sarah E Baker1, Eric C Wong, Courtney M Wheatley, William T Foxx-Lupo, Marina G Martinez, Mary A Morgan, Ryan Sprissler, Wayne J Morgan, Eric M Snyder.   

Abstract

INTRODUCTION: Epithelial Na channels (ENaCs) play a crucial role in ion and fluid regulation in the lung. In cystic fibrosis (CF), Na hyperabsorption results from ENaC overactivity, leading to airway dehydration. Previous work has demonstrated functional genetic variation of SCNN1A (the gene encoding the ENaC α-subunit), manifesting as an alanine (A) to threonine (T) substitution at amino acid 663, with the αT663 variant resulting in a more active channel.
METHODS: We assessed the influence of genetic variation of SCNN1A on the diffusing capacity of the lungs for carbon monoxide (DLCO) and nitric oxide (DLNO), together with alveolar-capillary membrane conductance (DM), pulmonary capillary blood volume, and alveolar volume (VA) at rest and during peak exercise in 18 patients with CF (10 homozygous for αA663 (AA group) and 8 with at least one T663 allele (AT/TT group)). Because of the more active channel, we hypothesized that the AT/TT group would show a greater increase in DLCO, DLNO, and DM with exercise because of exercise-mediated ENaC inhibition and subsequent attenuation of Na hyperabsorption.
RESULTS: The AT/TT group had significantly lower pulmonary function, weight, and body mass index than the AA group. Both groups had similar peak workloads, relative peak oxygen consumptions, and cardiopulmonary responses to exercise. The AT/TT group demonstrated a greater increase in DLNO, DLNO/VA, and DM in response to exercise (% increases: DLNO = 18 ± 11 vs 41 ± 38; DLNO/VA = 14 ± 21 vs 40 ± 37; DM = 15 ± 11 vs 41 ± 38, AA vs AT/TT, respectively). There were no differences between groups in absolute diffusing capacity measures at peak exercise.
CONCLUSION: These results suggest that genetic variation of the α-subunit of ENaC differentially affects the diffusing capacity response to exercise in patients with CF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776878      PMCID: PMC3501594          DOI: 10.1249/MSS.0b013e318266ebc3

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  41 in total

1.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

2.  Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF Mutation Analysis Consortium.

Authors:  X Estivill; C Bancells; C Ramos
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

3.  Impaired pulmonary diffusion during exercise in patients with chronic heart failure.

Authors:  A A Smith; P J Cowburn; M E Parker; M Denvir; S Puri; K R Patel; J G Cleland
Journal:  Circulation       Date:  1999-09-28       Impact factor: 29.690

4.  Downregulation of epithelial sodium channel (ENaC) by CFTR co-expressed in Xenopus oocytes is independent of Cl- conductance.

Authors:  H Chabot; M F Vives; A Dagenais; C Grygorczyk; Y Berthiaume; R Grygorczyk
Journal:  J Membr Biol       Date:  1999-06-01       Impact factor: 1.843

5.  Cl- transport by cystic fibrosis transmembrane conductance regulator (CFTR) contributes to the inhibition of epithelial Na+ channels (ENaCs) in Xenopus oocytes co-expressing CFTR and ENaC.

Authors:  M Briel; R Greger; K Kunzelmann
Journal:  J Physiol       Date:  1998-05-01       Impact factor: 5.182

6.  The incidence of cystic fibrosis.

Authors:  M R Kosorok; W H Wei; P M Farrell
Journal:  Stat Med       Date:  1996-03-15       Impact factor: 2.373

7.  Effect of exercise on the nasal transmucosal potential difference in patients with cystic fibrosis and normal subjects.

Authors:  S Alsuwaidan; A Li Wan Po; G Morrison; A Redmond; J A Dodge; J McElnay; E Stewart; C F Stanford
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

8.  Predicted values for clinical exercise testing.

Authors:  J E Hansen; D Y Sue; K Wasserman
Journal:  Am Rev Respir Dis       Date:  1984-02

9.  Determination of lung capillary blood volume and membrane diffusing capacity in man by the measurements of NO and CO transfer.

Authors:  H Guenard; N Varene; P Vaida
Journal:  Respir Physiol       Date:  1987-10

10.  Estimation of extravascular lung water in humans with use of 2H2O: effect of blood flow and central blood volume.

Authors:  C J Wallin; L G Leksell
Journal:  J Appl Physiol (1985)       Date:  1994-05
View more
  6 in total

1.  Genome-Wide Association Analysis of Single-Breath DlCO.

Authors:  Phuwanat Sakornsakolpat; Meredith McCormack; Per Bakke; Amund Gulsvik; Barry J Make; James D Crapo; Michael H Cho; Edwin K Silverman
Journal:  Am J Respir Cell Mol Biol       Date:  2019-05       Impact factor: 6.914

2.  Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis.

Authors:  Courtney M Wheatley; Sarah E Baker; Mary A Morgan; Marina G Martinez; Bo Liu; Steven M Rowe; Wayne J Morgan; Eric C Wong; Stephen R Karpen; Eric M Snyder
Journal:  Respir Med       Date:  2015-05-23       Impact factor: 3.415

3.  Seizure control in a patient with Dravet syndrome and cystic fibrosis.

Authors:  Barbara Schmalbach; Bettina Moeller; Sarah von Spiczak; Hiltrud Muhle; Ulrich Stephani; Nicolas Lang
Journal:  Epilepsy Behav Case Rep       Date:  2013-03-29

4.  Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis.

Authors:  Alexander L Bisch; Courtney M Wheatley; Sarah E Baker; Elizabeth R Peitzman; Erik H Van Iterson; Theresa A Laguna; Wayne J Morgan; Eric M Snyder
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2019-03-29

5.  Association of cystic fibrosis transmembrane conductance regulator with epithelial sodium channel subunits carrying Liddle's syndrome mutations.

Authors:  Arun K Rooj; Estelle Cormet-Boyaka; Edlira B Clark; Yawar J Qadri; William Lee; Ravindra Boddu; Anupam Agarwal; Richa Tambi; Mohammed Uddin; Vladimir Parpura; Eric J Sorscher; Cathy M Fuller; Bakhrom K Berdiev
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-26       Impact factor: 6.011

6.  Impaired cardiac and peripheral hemodynamic responses to inhaled β₂-agonist in cystic fibrosis.

Authors:  Erik H Van Iterson; Stephen R Karpen; Sarah E Baker; Courtney M Wheatley; Wayne J Morgan; Eric M Snyder
Journal:  Respir Res       Date:  2015-09-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.